Hamster fun and information

An 18% Jump on my Top Biotech Stock

“This latest AI initiative is big news for companies like RXRX.”

Karim Rahemtulla, Head Fundamental Tactician, Monument Traders Alliance

One of the top companies I’ve been recommending since the tariffs started is Recursion Pharmaceuticals (RXRX).

I’ve closed multiple winners on it so far in 2025 in The War Room.

And last week we got some news that sent shares soaring another 18%.

As you’ll see above, RXRX is moving up.

So what happened? Well, on Thursday the FDA announced plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with human-relevant methods.

The FDA said it will phase out animal testing requirements in favor of AI-based computational models of toxicity and cell lines and organoid toxicity testing.

So artificial intelligence is becoming more a part of the medical industry, and the goal of this initiative is to promise to accelerate cures and meaningful treatments for Americans while reducing animal use.

Implementation of this latest policy is expected to begin immediately.

Some other AI-powered biotech stock making moves after the announcement included Certara Inc. (CERT), Schrodinger Inc. (SDGR) and Simulations Plus (SLP).

All of the above names were up between 15% and 25% in after hours trading following the news.

But I believe it’s just the start.

While this latest FDA announcement is big for medical companies like RXRX, there are still plenty of upcoming catalysts on the company that could send it higher.

RXRX has several drug trials on the books, and good news on any one of them could send the stock higher.

It also has institutional buyers, including notable investor Cathie Wood, who bought 653,000 shares in January.

With all these catalysts, I’m predicting a 71% stock gain for RXRX this year.

The Ultimate Dip Buy

Make ONE Simple Trade… On ONE Special Ticker…
Within 15 Minutes AFTER Closing Bell…

Target 157% The Very Next Morning!

Action Plan: RXRX popped 18% on a new AI-related initiative from the FDA, and I believe there’s still plenty of catalysts that could send it higher.

It’s on my watchlist for a trade this week.

Click here to unlock my trades in The War Room today.

Can You Spot The Spike?

If so… you could spot BIG earnings moves… BEFORE they happen…

And target 293% in less than 24 hours…

If the stock moves up OR down… these trades win BIG!

Discover The Pre-Earnings Spike

Monument Traders Alliance

You are receiving this email because you subscribed to Trade of the Day Wake-Up Watchlist.
To unsubscribe from Trade of the Day Wake-Up Watchlist, click here.

Questions? Check out our FAQs. Trying to reach us? Contact us here.
Please do not reply to this email as it goes to an unmonitored inbox.

To cancel by mail or for any other subscription issues, write us at:
Trade of the Day | 14 West Mount Vernon Place | Baltimore, MD 21201

North America: 1.800.507.1399 | International: +1.443.353.4977
Website | Privacy Policy

Keep the emails you value from falling into your spam folder. Whitelist Trade of the Day.

Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation.

Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Monument Traders Alliance, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.

Download & Win!

Answers and Theme for the Week of April 7-13, 2025

RJ Hamster

An 18% Jump on my Top Biotech Stock

An 18% Jump on my Top Biotech Stock

“This latest AI initiative is big news for companies like RXRX.”

Karim Rahemtulla, Head Fundamental Tactician, Monument Traders Alliance

Share this:

Like this:

Related articles